HSBC Holdings’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-50,000
Closed -$461K 3258
2024
Q4
$461K Buy
+50,000
New +$483K ﹤0.01% 2233
2022
Q1
Sell
-33,700
Closed -$3.14M 3478
2021
Q4
$3.14M Sell
33,700
-8,300
-20% -$992K ﹤0.01% 1479
2021
Q3
$5.36M Buy
42,000
+1,800
+4% +$262K 0.01% 1122
2021
Q2
$6.72M Buy
+40,200
New +$6.51M 0.01% 986

Other funds holding TDOC

HSBC Holdings's TDOC Position: Q1 2026 in Review

HSBC Holdings increased its Teladoc Health (TDOC) stake by 35% in Q1 2026, buying an estimated $44.6K and bringing the position to 30,956 shares worth $162K. The position accounts for ﹤0.01% of the portfolio, ranked #2662.

HSBC Holdings first reported a position in TDOC in Q1 2017 and has held it in 29 quarters since. The position peaked at $14.1M in Q4 2021. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • HSBC Holdings held 30,956 shares of Teladoc Health worth $162K as of Q1 2026.
  • HSBC Holdings bought 7,956 Teladoc Health shares in Q1 2026, an estimated $44.6K.
  • Teladoc Health made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2662 holding.
  • HSBC Holdings first reported a position in Teladoc Health in Q1 2017 and has held it in 29 quarters since.
  • HSBC Holdings's Teladoc Health position peaked at $14.1M in Q4 2021.
  • 323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.